Research suggests that if you have a relative with MGUS, your risk is about three times higher than someone who doesn’t. Your odds of getting multiple myeloma and other blood cancers, such as ...

“As you look at the spectrum of precursor disease, it goes from MGUS to smoldering. And it’s really the high-risk (smoldering patients) that we have to hone in on and make sure clinically that they’re ...

And so, when people unfortunately progress from MGUS to smoldering to active myeloma, the bad protein grows, and it starts to affect our good blood. When in fact, unfortunately, it really goes to ...

It’s been almost 50 years since “monoclonal gammopathy of undetermined significance,” or MGUS, was identified as a precursor to multiple myeloma. Yet the debate over when and how to treat ...

Dr. Keith Roach DEAR DR. ROACH: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the ...

Many people who are diagnosed with MGUS or smoldering myeloma want to know what they can do to prevent these conditions from progressing into cancer. MSK myeloma specialist Urvi Shah, MD, is currently ...

Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic, premalignant plasma cell (PC) disorder characterized by serum monoclonal (M)-protein <3 g/dL, bone marrow clonal PCs <10%, ...

The study included 1,043 adults with immunoglobulin G (IgG), IgA, light-chain, and biclonal MGUS and an interpretable bone marrow sample. The researchers found that the C-statistic was 0.85 for ...

Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the ...